PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG CORONARY ARTERY DISEASE PATIENTS AND ITS ASSOCIATION WITH CAD SEVERITY

Amandeep; Smita Gupta; Nakul Gupta

doi:10.55489/njmr.13032023969

Authors

Amandeep Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly Utter Pardesh, India
Smita Gupta Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly Utter Pardesh, India
Nakul Gupta Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly Utter Pardesh, India

DOI:

https://doi.org/10.55489/njmr.13032023969

Keywords:

Non-alcoholic fatty liver disease, Coronary Artery Disease, Gensini score, FIB-4 index

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is a growing concern due to its potential to lead to liver transplants and its association with cardiovascular disease (CVD). However, the relationship between NAFLD and CVD remains debated, and non-invasive diagnostic methods for NAFLD are recommended. This study aimed to estimate the prevalence of NAFLD among patients with CAD and explore the association between CAD severity and the probability of developing NAFLD.

Methodology: A cross-sectional study was conducted among CAD patients. Patients with a history of infectious liver disease, pregnant or lactating individuals, and those with excessive alcohol consumption were excluded. Coronary angiography was performed to assess CAD severity using the Gensini score. Ultrasonography and non-invasive assessments, such as the Fibrosis-4 (FIB-4) index, were used to diagnose and stage NAFLD.

Result: The study included 156 CAD patients, with 79 (50.6%) being male. Out of total, 31 (19.8%) had severe, 79(50.6%) had moderate, and 46 (29.48%) had mild NAFLD. Male patients showed a significantly higher prevalence of severe NAFLD compared to females. There was no significant difference in the mean age of CAD patients across NAFLD severities. Severe NAFLD was associated with higher mean Gensini scores and FIB-4 values compared to mild to moderate NAFLD patients. A positive correlation was found between Gensini score and FIB4, suggesting that Gensini score could be an alternative to FIB4 in diagnosing NAFLD severity among CAD patients.

Conclusion: The study revealed a high prevalence of NAFLD among CAD patients, with severe NAFLD being associated with higher CAD severity.

References

Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011 [2023 May 12];141(4):1249-53. Doi: https://doi.org/10.1053/j.gastro.2011.06.061 PMid:21726509

Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver dis-ease. J Hepatol. 2008 Oct [2023 May 12];49(4):608-12. Doi: https://doi.org/10.1016/j.jhep.2008.06.018 PMid:18682312

Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J Hepatol. 2016 Sep 1 [2023 May 12];65(3):589-600. Doi: https://doi.org/10.1016/j.jhep.2016.05.013 PMid:27212244

Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015 May 1 [2023 May 12];61(5):1547-54. Doi: https://doi.org/10.1002/hep.27368 PMid:25125077

Santos RD, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis. 2019 Mar 1 [2023 May 12];282:110-20. Doi: https://doi.org/10.1016/j.atherosclerosis.2019.01.029 PMid:30731283

Marchesini G, Day CP, Dufour JF, Canbay A, Nobili V, Rat-ziu V, et al. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016 Jun 1;64(6):1388-402. Doi: https://doi.org/10.1016/j.jhep.2015.11.004 PMid:27062661

Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem. 2000;46(12):2050-68. Doi: https://doi.org/10.1093/clinchem/46.12.2050 PMid:11106350 PMCid:PMC7110382

Yokokawa T, Yoshihisa A, Kiko T, Shimizu T, Misaka T, Yamaki T, et al. Residual Gensini Score Is Associated With Long-Term Cardiac Mortality in Patients With Heart Failure After Percutaneous Coronary Intervention. Circ Rep. 2020 Feb 10 [2023 May 10];2(2):89-94. Doi: https://doi.org/10.1253/circrep.CR-19-0121 PMid:33693213 PMCid:PMC7929761

Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983 [2023 May 10];51(3):606. Doi: https://doi.org/10.1016/S0002-9149(83)80105-2 PMid:6823874

Gholoobi A, Gifani M, Gholoobi A, Akhlaghi S, Pezeshki Rad M, Baradaran Rahimi V. Relationship between the prevalence and severity of non‐alcoholic fatty liver disease and coronary artery disease: Findings from a cross‐sectional study of a referral center in northeast Iran. JGH Open. 2022 May 1 [2023 Jul 7];6(5):330. Doi: https://doi.org/10.1002/jgh3.12746 PMid:35601123 PMCid:PMC9120894

Agarwal A, Jain V, Singla S,. BBTJ of the, 2011 undefined. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. europepmc.org. [2023 Jul 7];

Perera N, Indrakumar J, Abeysinghe WV, Fernando V, Sa-maraweera WMCK, Lawrence JS. Non alcoholic fatty liver disease increases the mortality from acute coronary syn-drome: an observational study from Sri Lanka. BMC Cardiovasc Disord. 2016 Feb 12 [2023 Jul 7];16(1). Doi: https://doi.org/10.1186/s12872-016-0212-8 PMid:26869052 PMCid:PMC4751701

Kim JH, Moon JS, Byun SJ, Lee JH, Kang DR, Sung KC, et al. Fatty liver index and development of cardiovascular dis-ease in Koreans without preexisting myocardial infarction and ischemic stroke: a large population-based study. Cardiovasc Diabetol. 2020 May 2 [2023 Jul 7];19(1). Doi: https://doi.org/10.1186/s12933-020-01025-4 PMid:32359355 PMCid:PMC7196226

Wang P, Qiang H, Song Y, Dang Y, Luan H, Cao L, et al. Association between Nonalcoholic Fatty Liver and Gensini Score in Patients with Coronary Heart Disease: A Cross-Sectional Study. Cardiology. 2019 Dec 1 [2023 Jul 7];144(3-4):90-6. Doi: https://doi.org/10.1159/000502111 PMid:31665722

Chen LZ, Jing X Bin, Wu CF, Zeng YC, Xie YC, Wang MQ, et al. Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation. Dis Markers. 2021 [2023 Jul 7];2021. Doi: https://doi.org/10.1155/2021/6591784 PMid:34992694 PMCid:PMC8727161

Roh YH, Kang BK, Jun DW, Lee CM, Kim M. Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center. Sci Rep. 2021 Jun 30 [2023 Jul 7];11(1):13616. Doi: https://doi.org/10.1038/s41598-021-93038-6 PMid:34193951 PMCid:PMC8245508